FDA Advocacy
OPill is the first over-the-counter birth control pill available in the U.S. It is safe, effective, and will increase access to contraception for millions of women nationwide.
Late last night, the FDA announced that, effective immediately, both medication abortion and miscarriage patients would be able to access mifepristone via delivery from their providers or through mail-order pharmacies. This tremendous victory will ensure that patients and providers are protected during the pandemic.
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
How safe are the vaccines? How effective? Were they tested in people like me? Was the approval process influenced by political pressure? Here’s what we know.
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
On September 28 — the 20th anniversary of FDA’s approval of the abortion pill — we held a socially distanced protest in front of FDA headquarters and delivered the names of all 12,000+ of our petition signers.
Public comments urging the FDA’s Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.